Induction and identification of peripheral tolerance to ovalbumin administered intravenously or orally
Dekun Chen
Abstract
Dekun Chen
Abstract
【Objective】The study is to establish a model tolerance to ovalbumin.【Mathod】Mice gastrically intubated ovalbumin(OVA) had been divided into experiment group A,B,C,D,E and F and their corresponding control groups.Group A and B were at the dose of 50 or 100 μg every other day for 5 times.The rest were i.v.at the dose of 5,10,50 or 100 μg once for each.The oral administration groups and the intravenously injected groups were challenged with 200 μg OVA,at 7 days or 5 days interval,respectively.15 days later,mice were sacrificed.Lymphocytes responses were assessed by MTT method and antibody were tested by ELISA.And then group C and D injected 5 or 10 μg were exposed to the second and the third immunization.Antibody was detected at 15 days interval for 4 times.【Result】The regimen of OVA oral administration group A and B can induce Ag-specific lymphocytes profound suppression,with simulate index 0.603±0.03 and 0.715±0.08,repectively.And the anti-OVA IgG level was remarkablly affected.As to the intravenous group C and D,these lymphocytes from mice i.v.5 or 10 μg OVA were totally unresponsiveness in all mice tested,with index 0.096±0.01 and 0.083±0.01,respectively while group E and F were normally responded.Antigen-specific B cells were normally responded with the first immunization.But they had no reactivity to repetitious immunization and anti-OVA IgG were gently declined in 2 months.【Conclusion】Low dose of OVA intravenous injection can initiate specific immune tolerance while the oral administration in this experiment can just suppress the responses of T cells and B cells evidently.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
【Objective】The study is to establish a model tolerance to ovalbumin.【Mathod】Mice gastrically intubated ovalbumin(OVA) had been divided into experiment group A,B,C,D,E and F and their corresponding control groups.Group A and B were at the dose of 50 or 100 μg every other day for 5 times.The rest were i.v.at the dose of 5,10,50 or 100 μg once for each.The oral administration groups and the intravenously injected groups were challenged with 200 μg OVA,at 7 days or 5 days interval,respectively.15 days later,mice were sacrificed.Lymphocytes responses were assessed by MTT method and antibody were tested by ELISA.And then group C and D injected 5 or 10 μg were exposed to the second and the third immunization.Antibody was detected at 15 days interval for 4 times.【Result】The regimen of OVA oral administration group A and B can induce Ag-specific lymphocytes profound suppression,with simulate index 0.603±0.03 and 0.715±0.08,repectively.And the anti-OVA IgG level was remarkablly affected.As to the intravenous group C and D,these lymphocytes from mice i.v.5 or 10 μg OVA were totally unresponsiveness in all mice tested,with index 0.096±0.01 and 0.083±0.01,respectively while group E and F were normally responded.Antigen-specific B cells were normally responded with the first immunization.But they had no reactivity to repetitious immunization and anti-OVA IgG were gently declined in 2 months.【Conclusion】Low dose of OVA intravenous injection can initiate specific immune tolerance while the oral administration in this experiment can just suppress the responses of T cells and B cells evidently.
Key concepts: Ovalbumin, Immunization, Medicine, Antibody, Oral administration, Immunology, Internal medicine, Pharmacology